Pipeline
Scroll down
Product introduction
One ligand with dual functions, visible for diagnosis and effective for treatment, achieving integrated diagnosis and treatment.

Bivision is accelerating the development of an integrated, image-guided next-generation targeted radionuclide therapy to improve patients' lives. Unlike conventional drugs and radiopharmaceuticals, our focus is to bring integrated visualization and therapy to the market to enhance cancer patients' treatment outcomes.
The concept of "integrated visualization and therapy" combines a pair of closely related diagnostic and therapeutic drugs and achieves a "see and treat" approach using medical imaging devices. The molecular structures of the diagnostic and therapeutic drugs have the identical structure, only the differences primarily are in the chelated radioactive isotopes. This integrated visualization and therapy approach maximizes the benefits of personalized treatment.

Pipeline
Program
Category
Indication
Type
Discovery
PCC
IND
Phase I
Phase II
Phase III
NDA
Commercial
interest

JH002

Therapy

Prostate Cancer

Peptides

View More

JH003

JH004

Diagnostic

Therapy

Solid Tumor

Peptides&
small
molecules

N001

N002

Diagnostic

Therapy

Solid Tumor

Peptides&
small
molecules

*Each project includes a pair of visual diagnostic and therapeutic medications.